StockNod.com
Stock Trading Software - Chart Pattern Screener with Stock Alerts and Scans
Home
Chart Pattern Stock Alerts
Stock Scans
Stock Alerts Demo Video
Free Stock Newsletter
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
PowerShares ETF Trust Dynamic Biotech & Genome Port
(NY:
PBE
)
29.73
USD
+0.38 (+1.29%)
Official Closing Price
/ Updated:
6:40 PM EDT, May 17, 2013
/
Add to My Watchlist
View:
Quote
Overview
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Fund Overview
PowerShares ETF Trust Dynamic Biotech & Genome Port
Sector
Exchange Traded
NY
Net Assets
163.51M
Inception Date
Related Funds
NCYF
WEB
IWDE
IVOG
Quote
Price
29.73
Volume
33,469
Last Trade
May 17, 6:40pm
Change (%)
+0.38 (1.29%)
Prev. Close
29.35
YTD %
+30.18%
Dividend Yield
N/A
Performance
YTD
+6.89 (30.18%)
1 Month
+2.33 (8.51%)
3 Month
+4.71 (18.83%)
6 Month
+7.54 (33.98%)
1 Year
+8.34 (38.99%)
Chart
Charting
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Snag ISIS Even Lower Than Its Secondary?
May 10, 2013
Looking back to 2 days ago, Isis Pharmaceuticals, Inc. (ISIS) priced a 9,000,000 share secondary stock offering at $19.00 per share.
Read More
from
Market News Video
Uptrend Call Working As Powershares Dynamic Biotechnology & Genome Portfolio Stock Rises 23.4% (PBE)
May 09, 2013
from
Comtex SmarTrend® News Briefs
Top News
More News
Top Buys by Directors: Oconnell's $153.5K Bet on TECH
May 07, 2013
The directors of a company tend to have a unique inside view into the business, so when directors make major buys, investors are wise to take notice. Presumably the only reason a director of a company...
Read More
from
Market News Video
Top Buys by Directors: Loewenbaum II's $421.6K Bet on LMNX
May 06, 2013
The directors of a company tend to have a unique inside view into the business, so when directors make major buys, investors are wise to take notice. Presumably the only reason a director of a company...
Read More
from
Market News Video
Grab KERX 7.9% Cheaper Than Its Secondary?
May 02, 2013
Looking back to 92 days ago, Keryx Biopharmaceuticals Inc. (KERX) priced a 8,234,000 share secondary stock offering at $8.49 per share.
Read More
from
Market News Video
Uptrend Call Working As Powershares Dynamic Biotechnology & Genome Portfolio Stock Rises 20.2% (PBE)
May 02, 2013
from
Comtex SmarTrend® News Briefs
Opko Health Enters Oversold Territory (OPK)
May 01, 2013
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a...
Read More
from
Market News Video
Bullish Two Hundred Day Moving Average Cross - LMNX
April 30, 2013
In trading on Tuesday, shares of Luminex Corp (LMNX) crossed above their 200 day moving average of $17.70, changing hands as high as $18.06 per share. Luminex Corp shares are currently trading up about...
Read More
from
Market News Video
Powershares Dynamic Biotechnology & Genome Portfolio Up 19.7% Since SmarTrend Uptrend Call (PBE)
April 24, 2013
from
Comtex SmarTrend® News Briefs
PDL BioPharma Inc (PDLI) Shares Cross Below 200 DMA
April 17, 2013
In trading on Wednesday, shares of PDL BioPharma Inc (PDLI) crossed below their 200 day moving average of $7.32, changing hands as low as $7.31 per share. PDL BioPharma Inc shares are currently trading...
Read More
from
Market News Video
Uptrend Call Working As Powershares Dynamic Biotechnology & Genome Portfolio Stock Rises 15.8% (PBE)
April 17, 2013
from
Comtex SmarTrend® News Briefs
Myriad Genetics, Inc. (MYGN) Shares Cross Above 200 DMA
April 15, 2013
In trading on Monday, shares of Myriad Genetics, Inc. (MYGN) crossed above their 200 day moving average of $26.39, changing hands as high as $28.11 per share.
Read More
from
Market News Video
Under The Hood: An Unheralded Biotech ETF
April 11, 2013
Another day, another set of fresh all-time highs for the major biotechnology ETFs. Biotech investors were treated to the same feat in late March , but as health care has continued to be a...
Read More
from
Latest Articles from Benzinga.com
Thursday's ETF Movers: PBE, PSCM
March 28, 2013
In trading on Thursday, the Dynamic Biotechnology & Genome Portfolio ETF (PBE) is outperforming other ETFs, up about 1.5% on the day. Components of that ETF showing particular strength include shares...
Read More
from
ETF Channel
Top Buys by Directors: Laukien's $1.4M Bet on BRKR
March 20, 2013
The directors of a company tend to have a unique inside view into the business, so when directors make major buys, investors are wise to take notice. Presumably the only reason a director of a company...
Read More
from
Market News Video
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here